Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Steven Brandwein Insider Profile
4 Followers
Steven Brandwein, Interim Chief Financ. Officer at Arcadia Biosciences, holds 49.97K shares in Arcadia Biosciences (Ticker: RKDA).
Steven Brandwein has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
100.00%
A breakdown of Steven Brandwein's holdings
Insider Roles
Interim Chief Financ. Officer
Roles that Steven Brandwein holds in companies
Most Profitable Insider Trade
Stock:
Rating:Informative Buy
Date:Oct 02, 2015 - Oct 02, 2016
Return:-35.80%
The most profitable trade made by Steven Brandwein
Steven Brandwein's Trading History
List of latest transactions for each holding click on a transaction to see Steven Brandwein's performance on stock
You May Also Like
Steven Brandwein insider profile FAQ
What is the percentage of profitable transactions made by Steven Brandwein?
The percentage of profitable transactions made by Steven Brandwein is ―.
What is the average return per transaction made by Steven Brandwein?
The average return per transaction made by Steven Brandwein is ―.
What stocks does Steven Brandwein hold?
Steven Brandwein holds: RKDA stocks.
What was Steven Brandwein’s latest transaction?
Steven Brandwein latest transaction was an Uninformative Sell of $20.62K.
What was Steven Brandwein's most profitable transaction?
Steven Brandwein’s most profitable transaction was an Informative Buy of RKDA stock on October 2, 2015. The return on the trade was -35.80%.
What is Steven Brandwein's role in Arcadia Biosciences?
Steven Brandwein's role in Arcadia Biosciences is Interim Chief Financ. Officer.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.